Why lithium studies for ALS treatment should not be halted prematurely

Galila Agam; Adrian Israelson

doi:10.3389/fnins.2014.00267

Why lithium studies for ALS treatment should not be halted prematurely

Galila Agam
, Adrian Israelson

Research output: Contribution to journal › Comment/debate

Original language	American English
Article number	267
Journal	Frontiers in Neuroscience
Volume	8
Issue number	SEP
DOIs	https://doi.org/10.3389/fnins.2014.00267
State	Published - 1 Jan 2014

Keywords

ALS
Effective blood levels
Lithium
Mouse strains
Riluzole

ASJC Scopus subject areas

General Neuroscience

Access to Document

10.3389/fnins.2014.00267

Cite this

@article{546e800e12914d8fb9507a58b63a2025,

title = "Why lithium studies for ALS treatment should not be halted prematurely",

keywords = "ALS, Effective blood levels, Lithium, Mouse strains, Riluzole",

author = "Galila Agam and Adrian Israelson",

year = "2014",

month = jan,

day = "1",

doi = "10.3389/fnins.2014.00267",

language = "American English",

volume = "8",

journal = "Frontiers in Neuroscience",

issn = "1662-4548",

publisher = "Frontiers Media SA",

number = "SEP",

}

TY - JOUR

T1 - Why lithium studies for ALS treatment should not be halted prematurely

AU - Agam, Galila

AU - Israelson, Adrian

PY - 2014/1/1

Y1 - 2014/1/1

KW - ALS

KW - Effective blood levels

KW - Lithium

KW - Mouse strains

KW - Riluzole

UR - https://www.scopus.com/pages/publications/84907945176

U2 - 10.3389/fnins.2014.00267

DO - 10.3389/fnins.2014.00267

M3 - Comment/debate

C2 - 25228854

SN - 1662-4548

VL - 8

JO - Frontiers in Neuroscience

JF - Frontiers in Neuroscience

IS - SEP

M1 - 267

ER -

Why lithium studies for ALS treatment should not be halted prematurely

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this